More antibiotic-resistant Salmonella cases reported in Colorado

Salmonella outbreak in ColoradoThe Colorado Department of Public Health and Environment (CDPHE) issued an updated Salmonella outbreak alert on Juy 31. In it, CDPHE announced that 21 cases of antibiotic-resistant Salmonella Newport have been reported in Colorado. Most ill individuals sick with Salmonella Newport reported experiencing symptoms of Salmonella infection beginning in late June or early July, and while CDPHE did not announce that a second ground beef recall had been issued, the agency did warn consumers about the possibility that ground beef they have in their freezers could be contaminated with antibiotic-resistant strains of Salmonella.

This most recent drug-resistant Salmonella outbreak follows on the heels of a July 22, 2009 USDA announcement that King Soopers was recalling ground beef for Salmonella contamination. The recalled meat was also contaminated with antibiotic-resistant Salmonella (DT104), and was source of a Salmonella outbreak among residents of several states. According to news reports, most of the illnesses reportedly associated with the earlier Salmonella DT104 outbreak were also among Colorado residents. 

In its July 31 press release, CDPHE stated:

This is the second large Salmonella outbreak that the department has investigated in July. Both outbreaks have been linked to ground beef. Further investigation with the USDA in to the source of the meat in this outbreak is ongoing.

Alicia Cronquist, the foodborne disease epidemiologist at the state health department, said, “We can’t be certain that ground beef is the source of these infections, but we are concerned enough that it might be and want consumers to be aware.”

Antibiotic-resistant Salmonella contamination in ground beef has increasingly been implicated as the source of human illness. On its drug-resistant Salmonella page, the World Health Organization states:

The emergence of Salmonella strains that are resistant to commonly used antimicrobials should be particularly noted by clinicians, microbiologists and those responsible for the control of communicable diseases, as well as the food producers including the food industry. Control of drug-resistant Salmonella is most efficiently achieved through the reduction of antimicrobial use. Prudent usage in food animals should be combined with good husbandry, good abattoir practice and good hygiene at all stages in the food production chain, from processing plants to kitchens and food service establishments. These combined efforts should reduce the numbers of the relevant strains in food animals and lower the risk of contamination by resistant Salmonella at all stages in the food production chain.

While activities addressing the occurrence of antimicrobial resistance in foodborne microorganisms are ongoing, the magnitude of the problem is largely unknown in many countries. International collaborative efforts, including efforts in support of surveillance and risk assessment, need to be increased.

H.R. 1549 - Preservation of Antibiotics for Medical Treatment Act of 2009 proposes the restriction of antibiotic use in feed animals to therapeutic purposes only to prevent the emergence of additional antibiotic-resistant strains of Salmonella and other foodborne pathogens in our food supply. The passage of this bill could be a huge step toward preventing future outbreaks like the two that have struck in Colorado this summer. 

Ground beef contaminated with antibiotic-resistant Salmonella recalled

The United States Department of Agriculture's Food Safety and Inspection Service (FSIS) announced that King Soopers, Inc. of Denver, Colorado, was recalling 466,236 pounds of ground beef products due to potential Salmonella Typhimurim DT104 contamination yesterday.  The recall was initiated after public health officials from the Colorado Department of Public Health and Environment and the Centers for Disease Control and Prevention traced a Salmonella Typhimurim DT104 outbreak among Colorado residents to the ground beef products.

Salmonella Typhimurium DT104 is an antibiotic-resistant strain of Salmonella, which can prove to be problematic for physicians treating patients who have eaten the contaminated ground beef and have become ill with Salmonella infections. 

In her 1997 paper, "Emergence of a Highly Virulent Strain of Salmonella typhimurium," M. Ellin Doyle, Ph.D. at the Food Research Institute at the University of Wisconsin-Madison wrote:

Some evidence indicts the increased use of veterinary drugs as a factor in the dramatic increase in drug resistance. Resistance to ciprofloxacin in DT104 isolates has increased from 1% in 1994 to 6% in 1995, coincident with the licensing of this drug for veterinary use in the UK in 1994 (2). Resistance to trimethoprim (present in 27% of DT104 isolates) may have been acquired in response to the use of this drug to combat bovine infections with DT104 resistant to other drugs. Surveys of S. typhimurium isolates from cattle and humans in Australia (16), France (17), Hong Kong (18), and Spain (19) all reveal an increased incidence of resistance to multiple antibiotics in this organism.

As yet, there have been no reports of S. typhimurium DT104 in the USA, but the rapid rise of this organism in the UK warns us in the USA to be vigilant. Increasing resistance to so many different antibiotics makes it very difficult to treat severe cases of human salmonellosis.

By 2000, if not before, Salmonella Typhimurium DT104 had spread to the United States.  Researchers from the Department of Veterinary Microbiology and Pathology, Washington State University-Pullman published an article titled, "Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States" after investigating a Salmonella Typhimurium DT104 outbreak among residents of the Pacific Northwest. 

In his testimony on food safety before the U.S. House Committee on Energy and Commerce last March, William K. Hubbard stated:

Those peanut butter, pepper and spinach examples are just a few of the breakdowns that have caused our citizens to question their leaders’ ability to carry out this most quintessential governmental function – the safety of commodities that are so necessary for a healthy society. Indeed, some argue that our food supply is becoming less safe despite the progress that has been made in science and medicine in recent decades. It is certainly clear that there are trends that cry out for intervention by the Congress, namely:

  • New pathogens have emerged in foodstuffs, some unknown to science in years past, that are especially lethal when they contaminate our food. They have exotic names, such as Enterobacter sakazakii, E Coli 0157:H7, Listeria monocytogenes, Vibrio cholerae 0139, and Salmonella Typhimurium DT104, (emphasis added) but they all pose a significant threat of severe illness and death when our citizens contract them. And there is an expectation among scientists that yet more of these threats will be discovered in the future.

That Salmonella Typhimurium DT104 had not been identified as the source of an outbreak in the United States prior to 1997, and this "especially lethal" pathogen has been identified as the source of several outbreaks, including the current outbreak among Colorado residents, is alarming. 

The Colorado Salmonella Typhimurium DT104 outbreak should spark more conversation about HR 1549 - Preservation of Antibiotics for Medical Treatment Act of 2009, which aims to preserve the use of antibiotics in food animals strictly for therapeutic use.

Antibiotic use in food animals addressed by House committee

The New York Times reports on yesterday’s House Committee on Rules hearing on "H.R. 1549 - Preservation of Antibiotics for Medical Treatment Act of 2009." In today’s article, titled, “Administration Seeks to Restrict Antibiotics in Livestock,” the Times refers to testimony by FDA Deputy Commissioner, Joshua M. Sharfstein, M.D. 

In his testimony, (pdf) Dr. Sharfstein explained that antimicrobial resistance has emerged as a threat to public health for multiple reasons, including:

  • Physicians prescribing antimicrobials too frequently or inappropriately
  • Patients failing to complete a prescribed course of antimicrobial, making it more likely that surviving microbes will develop resistance
  • Antimicrobial use in animals
  • Nontherapeutic use of antimicrobial drugs of human importance in food-producing animals

In his written testimony, Dr. Sharfstein stated:

To avoid unnecessary development of resistance under conditions of constant exposure (growth promotion/feed efficiency) to antibiotics, the use of antimicrobials should be limited to those situations where human and animal health are protected. Purposes other than for the advances of animal or human health should not be considered judicious use. Eliminating these uses will not compromise the safety of food.

In short, Dr. Sharfstein advocated for the discontinuation of the use of administering antibiotics to otherwise healthy food animals for the sole purpose of generating growth or promoting feed efficiency. 

To further Dr. Sharfstein’s point, in his testimony (pdf) before the House Committee, Robert P. Martin, Senior Officer of The Pew Environment Group, presented the findings of The Pew Commission on Industrial Farm Animal Production, an independent commission funded by a grant from The Pew Charitable Trusts Health to investigate the problems associated with industrial farm animal production. Mr. Martin stated:

antibiotic resistant bacteria in food animalsThe Commission released its full report on April 29, 2008, that included 24 primary recommendations. The Commission was so concerned about the indiscriminate use of antibiotics in food animal production, and the potential threat to public health, that five of those recommendations deal with antibiotic use. The top two public health recommendations call for the end on the non-therapeutic use of antibiotics in food animal production and set strict definitions for their use.

The top recommendation, submitted in Mr. Martin’s written testimony, is to testrict the use of antimicrobials in food animal production to reduce the risk of antimicrobial resistance to medically important antibiotics. According to the Commission, this can be achieved by:

  1. Phasing out and banning the use of antimicrobials for non-therapeutic (i.e. growth promoting) use in food animals
  2. Immediately banning any new approvals of antimicrobials for non-therapeutic uses in food animals and retroactively investigating antimicrobials previously approved.
  3. Strengthening recommendations in FDA Guidance #152 which requires the FDA determine that the drug is safe and effective for its intended use in the animal prior to approving an antimicrobial for a new animal drug application.
  4. Facilitating the reduction in industrial farm animal production use of antibiotics and educating producers on how to raise food animals without using non-therapeutic antibiotics, the USDA’s extension service should be tasked to create and expand programs that teach producers the husbandry methods and best practices necessary to maintain the high level of efficiency and productivity they enjoy today.

H.R. 1549, which is supported by the American Medical Association and other public health-related organizations, is opposed by the National Pork Producers Council and other farm organizations. 

According to the Times article, the Union of Concerned Scientists estimates that up to 70 percent of antibiotics used in the United States is given to healthy animals used in food production (chickens, pigs, cattle) to promote growth or prevent illness. 

All testimony from yesterday’s hearing can be found on the Committee on Rules website.

Some bacteria that cause food poisoning resistant to antibiotic treatment

Mike the Mad Biologist wrote a post titled, "Shigella, Children, and Antibiotic Resistance, in which he cites a study by the Centers for Disease Control and Prevention. The CDC study emphasized the fact that some strains of Shigella, a bacterium that is sometimes foodborne and can lead to serious illness and even death in children and populations with compromised immune systems, have become resistant to antibiotic treatment. From Mike the Mad Biologist's Post:

In the developed world, shigellosis, a diahrreal disease caused by the bacterial species Shigella, typically isn't considered dangerous, even though it makes about 450,000 ill in the U.S. To shorten the length of illness and to reduce potential infection of other people, antibiotics are typically prescribed, usually cotrmoxazole or ampicillin. However, recent shigellosis outbreaks are cause for concern (italics mine):

Surveillance data for antimicrobial resistance among all S. sonnei isolates received by NARMS during 1999--2003 indicated that 80% of the isolates were resistant to ampicillin and 47% to TMP/SMX [cotrimoxazole]; 38% were resistant to both drugs (6). In the two outbreaks described in this report, resistance to both ampicillin and TMP/SMX was 89%, complicating shigellosis treatment in these communities.

Mike the Mad Biologist points out that hand washing can prevent Shigella infection, and that a national approach to preventing future outbreaks is necessary, since, "bacteria and viruses really don't care about state boundaries." See the Shigella blog for more information about Shigella outbreaks.

Time bombs lace most U.S. meat

Diane Carman of the Denver Post reports that on a blistering hot day, rancher Sue Jarrett took two carloads of city slickers on the tour de manure. They started at the sprawling Swift & Co. feedlot in Greeley, checked out a confined buffalo farming operation, peeked in on some dairies, visited one of the largest feedlots in the world in Yuma and ended up at her ranch near Wray.

She fixed them supper, and they stayed all night. She served pork roast and roast beef, a big salad, stir-fried vegetables. The best part, though, was what she didn't serve.

Because she knew how the animals had been raised, she could say with confidence that they weren't laced with antibiotics and they weren't hosts for antibiotic-resistant bacteria like most of the animals raised for meat in America.

And this was one crowd that could really appreciate it.

The guests of the natural-meat activist were scientists and activists who lobby Congress and federal agencies to take action to preserve antibiotics for essential medical treatment.

And unlike most of us, they pay very close attention to what they eat.

"The No. 1 public health problem today is the evolution of antibiotic-resistant bacteria," said Margaret Mellon, food and environment program director for the Union of Concerned Scientists.

The World Health Organization, the American Public Health Association and the National Academy of Sciences are just a few of the groups that have called for urgent action to address the problem.

Last week, they got news that the Food and Drug Administration is finally starting to pay attention. The FDA withdrew its approval of the use of a Cipro-like antibiotic in poultry feed, albeit five years after the medical community declared the situation an emergency.

Poultry producers had been feeding chickens these antibiotics since 1995. In 2000, scientists began raising concerns about the appearance of antibiotic-
resistant bacteria. In 2002, the Centers for Disease Control and Prevention confirmed that resistance to Cipro in Campylobacter, a potentially deadly cause of bacterial food poisoning in humans, had risen 21 percent.

The FDA was slow to withdraw its approval of the antibiotic-laced poultry feed because of pressure from the pharmaceutical company Bayer, which has made untold millions on sales to poultry farmers.

But taking the antibiotics out of poultry feed is only a first step, Mellon said.

More than 24 million pounds of antibiotics are routinely fed to livestock in this country every year, and concern for the consequences has led European countries - and many others around the world - to stop importing American beef and pork.

"The antibiotic issue just gives our competitors in the marketplace another card to play," Jarrett said.

Denmark, the world's largest pork producer, has proved that nontherapeutic antibiotics are unnecessary in livestock production, she said.

"If cattle and pigs are raised in a healthy environment, they don't need antibiotics in their feed to thrive," she said.

But short of purchasing a side of beef or a pig on the hoof from a small farmer such as Jarrett, American consumers have a hard time finding meat that isn't host to super-germs that have evolved beyond the power of Cipro to stop them.

In this country, big corporations control the packing plants, and meat is one of the only food sectors to escape labeling requirements.

That labeling is coming, Jarrett said.

The same consumers who have made organic, hormone-free, antibiotic-free milk the fastest growing segment of the market surely would pay attention to labels on beef, pork and chicken that would include information about the powerful drugs in their feed.

Super-germs and the drugs that are spawning them are the "little ticking time bombs" of public health, Mellon said.

The FDA should act immediately to disarm them instead of just fattening the hindquarters of big agriculture and the pharmaceutical industry and treating the rest of us like, well, so much manure.

FDA Bans Use Of Antibiotic In Poultry

Anna Wilde Mathews and Zachary Goldfarb of the Wall Street Journal report that fearing that the animal drug Baytril -- used to fight infections in chickens -- could pose health risks to humans, the Food and Drug Administration decided to ban its use in poultry.

The decision yesterday to restrict the Bayer AG antibiotic, which takes effect Sept. 12, marks the first time that the agency has ended the use of an animal drug because of worries that it could lead to antibiotic-resistant pathogens in humans.

"We made the determination that the drug was not safe," said Stephen Sundlof, director of the FDA's Center for Veterinary Medicine, which first asked for the drug's removal in 2000. The FDA's top official "has confirmed our original decision." The FDA's standard is that food from animals that have taken a particular drug must carry a "reasonable certainty of no harm," and the agency didn't feel that poultry treated with Baytril met that standard, he said.

A spokesman for Bayer's animal-health division said the ruling by FDA Commissioner Lester Crawford, a veterinarian, was "very disappointing" and the company hadn't yet decided whether it would appeal in federal court. Bayer has argued that its drug can't be tied to the rise of resistant bacteria.

The FDA's move highlights growing concern that animal bacteria transmitted to humans -- by means such as eating infected poultry -- may be resistant to antibiotics commonly prescribed to fight human illness. The resistant bugs can arise in animals that are given antibiotics similar to human versions.

More broadly, infectious-disease specialists have warned that a slowdown in development of new classes of antibiotics for humans will leave doctors with few defenses against the rise of resistant pathogens.

Consumer groups applauded the FDA's announcement, which they said was an important step in the battle against resistant bacteria. The use of Baytril and similar drugs is "eroding, in a dramatic way, the effectiveness of human-use drugs," said Margaret Mellon, an official with the Union of Concerned Scientists. That group and others have called for the U.S. to take more steps to rein in the use of antibiotics in animals, and have backed a bill in Congress that would add restrictions.

Baytril is used to battle respiratory infections in turkeys and chickens, and it can be given to an entire flock through water if a few birds become sick. The FDA's move doesn't affect use of the drug in cows or pets such as dogs.

The FDA's concern is that use of Baytril is leading to a resistant form of the bacteria Campylobacter. Campylobacter causes food-borne gastrointestinal illness, and complications from it can include arthritis and rare blood infections, the FDA said. The agency has said that since Baytril's approval in 1996, a growing proportion of Campylobacter infections in humans have proved resistant to an important class of antibiotics called fluoroquinolones. Both Cipro, a popular human antibiotic, and Baytril are fluoroquinolones.

Use of Baytril had already been sharply curtailed, as many big producers had ceased using it. Perdue Farms Inc., for one, said it had never used the drug. Large fast-food chains such as McDonald's Corp. had already instructed their chicken suppliers not to use Baytril or other fluoroquinolones.

Abbott Laboratories withdrew a similar antibiotic from the market voluntarily in 2000. But Bayer chose to fight the agency through an unusual administrative court process. The company won support from some members of Congress. But in March of last year, an administrative-law judge sided with the FDA's veterinary center. Now, the FDA's top official, Dr. Crawford, has also agreed.

Industry officials said the loss of the drug could leave few options to treat certain animal infections. Elizabeth Krushinskie, a vice president at the U.S. Poultry and Egg Association, an industry group, said Baytril was the most effective drug available to treat serious infections in poultry. The Animal Health Institute, which represents makers of animal drugs, said in a statement that it too was "disappointed."

Eric Gonder, a veterinarian with the turkey producer Goldsboro Milling Co. said the loss of Baytril will lead to a "small but aggravating increase in mortality" among the company's birds. In an average year, he said, about 5% of the company's eight million birds would receive the drug.

The U.S. has more lenient policies on the use of antibiotics in animals than a number of other countries. European countries have banned producers from using such drugs to promote growth if they are important for human use, and the European Union will require members to end the use of all antibiotics for animal growth by next year. The U.S. still allows such use.

In a report last year, the Government Accountability Office, the investigative arm of Congress, called for the U.S. to move more quickly in evaluating the potential risks posed by animal antibiotics that are also important products for human health. The FDA's Dr. Sundlof said the agency was in the process of reviewing the products, and "can only go as fast as the scientific information will allow us to."

In 2003, the FDA unveiled new standards for approval of animal drugs that factor in the potential risk of resistant bacteria arising in humans. Under those standards, Dr. Sundlof said, it is nearly impossible to get a new antibiotic approved as a growth promoter for animals.

Antibiotic Resistance

An excerpt from Secret Agents: The Menace of Emerging Infections by Madeline Drexler, published by the Joseph Henry Press (2002). Reprinted by permission. To read the full text online, go to http://www.nap.edu/.

Some experts estimate more than half of the antibiotics produced in this country are fed to farm animals, mostly to boost their growth rate. In this excerpt from her book Secret Agents, Madeline Drexler chronicles how that practice has led to strains of drug-resistant bacteria, forcing doctors to prescribe higher and higher doses of medicine to combat these more resilient pathogens. "Farms are some of the most insidious sources of antibiotic resistance," Drexler writes. "Whether carnivore or vegetarian, you cannot avoid the aftermath of antibiotics applied lower in the food chain." A former medical columnist for The Boston Globe, Drexler was a Knight Science Journalism Fellow at the Massachusetts Institute of Technology from 1996 to 1997.

Not all resistant microbes spring from misguided human medicine. Farms are some of the most insidious sources of antibiotic resistance. As mentioned in Chapter 3, antibiotics are routinely fed in tiny amounts to farm animals -- not to fend off disease, but to boost growth. And low-level use of antibiotics is a perfect way to foster resistant organisms. In recent years, livestock industry experts had estimated that 40 percent of antibiotics produced in the United States went to farm animals. In 2001, however, a report from the Union of Concerned Scientists, a Cambridge, Massachusetts-based environmental advocacy group, raised this estimate to a whopping 70 percent. Public health experts have long worried that farmers are squandering human life-saving drugs on animals that are not even sick.

Take Campylobacter, the most common bacterial cause of foodborne illness. In 1995, American poultry farmers began using a fairly new class of drugs known as fluoroquinolones to treat respiratory infections in poultry. In people, these broad-spectrum, low-toxicity drugs are some of the most prized antibiotics today, because they are slow to breed resistance and are effective against some of the hardest-to-treat infections. Almost immediately after poultry farmers began dosing their birds with the medication, thousands of people who ate undercooked chicken contaminated with fluoroquinolone-resistant strains of campy themselves became infected with the drug-resistant bacteria. Before the drug was used, no Campylobacter specimens cultured from hospital patients had been resistant; today, nearly a fifth are, and the figure is sure to rise.

Even more dangerous than drug-resistant Campylobacter is resistant Salmonella, which is also present in poultry and meat. In human medicine, fluoroquinolones are the preferred treatment for invasive, and often life-threatening, Salmonella infections. Yet today, doctors are resorting to higher and higher doses of fluoroquinolones to treat Salmonella -- a possible prelude to full-blown resistance. And now there's a frightening new wrinkle in treating the organism. In 1998, a 12-year-old Nebraska boy picked up a Salmonella infection from his family's cattle that was resistant to ceftriaxone -- one of the cephalosporin class of antibiotics -- as well as a dozen other antibiotics. Fortunately, he survived when doctors treated him with a combination of other drugs. But when this unprecedented case was reported in 2000, it terrified public health officials. Ceftriaxone is one of the few antibiotics that reliably kills most bacteria. And it is the drug of choice for children whose Salmonella infections have entered the bloodstream -- a condition that kills about 1,000 Americans every year. Ceftriaxone is also the drug that doctors turn to when treating young victims; because of worries about bone growth, quinolones are not approved for children. Since 2000, more cases of ceftriaxone-resistant Salmonella in people have turned up. "This Salmonella is so multiresistant," says the CDC's David Bell, "there are no good drugs left that are approved for children." To history-minded physicians, the situation evokes futile attempts at the turn of the last century to treat typhoid fever, another Salmonella infection. Extrapolating from subsequent studies of patients, health officials calculate that tens of thousands of Salmonella cases each year are ceftriaxone-resistant. The clinical problem also touches on a moral quandary: ceftriaxone is not used as a growth promoter, but rather to treat sick animals. "It portends a dilemma," says the CDC's Fred Angulo. "Societally, what do you want to do: treat sick people or sick animals?"

Another foodborne infection is VRE -- yes, the same bug that wreaks so much havoc in critically ill hospital patients. In this country, VRE isn't primarily foodborne; the organism is most often bred by massive vancomycin use in hospitals. It's a different story in Europe. Soon after farmers there began feeding avoparcin, a growth promoter related to vancomycin, to livestock in 1974, the animals developed vancomycin-resistant enterococci. (Because it may be a carcinogen, avoparcin never received approval in the United States.) In 1986, France found its first human patient with VRE. Within a few years, the bacterium spread throughout human intestinal tracts on the Continent. U.S. public health experts believe that at least some of the VRE organisms in this country may have come from Europe and then proliferated under the selective influence of vancomycin in hospitals here.

But while foodborne vancomycin-resistant enterococcus infections are uncommon in the United States, a similar chain of events is starting to happen here with another drug. For more than a quarter century, American poultry farmers have used the growth promoter virginiamycin in chicken feed. In chickens, the drug helped breed enterococci that are resistant to virginiamycin's human-use cousin, Synercid. Synercid is the other "last-resort" antibiotic, approved for humans in 1999. Yet as a frightening presentiment to the drug's potential downfall, more than half of grocery-store chickens carry bacteria impervious to this end-of-the-line human drug. People are picking up these resistant bacteria in their meals. At any one time, at least 1 percent of the U.S. population is carrying Synercid-resistant enterococci. Usually, these intestinal bacteria are expelled as food moves through the intestines, never causing a problem. But in the rare instance that such an individual enters the hospital -- say, for a hip replacement -- and happens to be treated with Synercid, the resistant enterococcal bacteria in the gut will go wild, threatening an infection that no antibiotic can quell.

One of the most frightening and enigmatic foodborne pathogens is a drug-resistant strain of Salmonella typhimurium. Known as Definitive Type 104, or DT 104, it defies five important classes of drugs in the United States; in Europe, where it surfaced in 1984, it thwarts seven. This monster resistance has helped it spread in cattle, because in animals that receive any one of these drugs, DT 104 gains an advantage. In the U.S., hundreds of thousands of people suffer DT 104 infections annually. Raw milk is a common culprit, the bacterium having infiltrated dairy herds. In 1997, for example, more than 100 Californians became sick from DT 104 in two overlapping outbreaks in Hispanic communities, where residents ate homemade Mexican-style cheese made from unpasteurized milk and sold by street vendors and specialty markets.

When scientists tried to figure out where this renegade came from, they were shocked. DT 104's resistance genes were a strange combination -- so strange, they had never before been seen in Salmonella. Where they had turned up was worlds away: in Asian aquaculture, where fish have been regularly treated with antibiotics since the early 1980s. So how did they land in the American heartland? One theory holds that some of those Asian fish may have been ground up into fish meal, an international commodity often fed to pigs and poultry. Or DT 104's resistance genes may have found their way into animal breeding stock, perhaps through the rendered protein of other animals. However it happened, DT 104 appeared more or less simultaneously around the world in the 1980s, suggesting that the animals acquired these alien bacteria en masse.

In 1969, Britain's Swann Committee concluded that antibiotics used in human therapy or those that promote cross-resistance in people should be banned from animal growth promotion. Unfortunately, livestock producers hew to the position that whatever drugs they feed their animals are proprietary secrets. Besides, say industry officials, they need antibiotics to produce safe and affordable food. A 1999 report published by the Institute of Medicine and the National Research Council questioned this claim. Using the livestock industry's own estimates, the report calculated that if farmers quit using antibiotic growth promoters, the added costs would be less than $10 per American consumer per year. And a 2001 United States Department of Agriculture report showed that hog farmers actually lose money by giving pigs antibiotics that promote growth; while animals do fatten up more, the extra poundage expands overall supply and drives down market prices.

Poultry and livestock aren't the only creatures being dosed with drugs. Salmon, catfish, and trout on domestic fish farms get antibacterial drugs in the water. Honeybees get antibiotics in their hives. And each year, an estimated 300,000 pounds of antibiotic pesticides drift down on fruit trees and other crops to control or prevent bacterial infections such as fire blight. That disease is caused by the pathogen Erwinia, a bacterial cousin of E. coli, Salmonella, and Shigella. Erwinia now resists both streptomycin, an old drug, and tetracycline. Researchers don't know if the fresh fruit invitingly stacked in your supermarket is delivering drug-resistant genes to your intestines. According to microbiologist Abigail Salyers, both the use of untreated or partially treated water for irrigation or for washing vegetables, or the use of manure as a fertilizer for vegetables and fruits could contaminate food plants with antibiotic-resistant bacteria. Proving that no good deed goes unpunished, a 1993 study found higher levels of multidrug-resistant bacteria in intestines of vegetarians than in meat eaters. Whether carnivore or vegetarian, you cannot avoid the aftermath of antibiotics applied lower in the food chain.